





Rift Valley Fever Virus (RVFV) is an arbovirus most commonly spread through mosquitos or infected animal tissues, and can infect a wide range of animals with the biggest impact being on ruminants and humans. RVFV is a major concern for possible spread into the America’s as well as it being used as a biological weapon due to the high mortality rate associated with aerosolizing the virus. This review will focus on the neurological disease seen in the developed animal models and the histology being used in the research of RVFV. The first model developed was the mouse model and is most useful because of the developed knockouts in mice. Certain mice can consistently produce neurological disease through intranasal infection, and histological examination of brain tissue shows widespread encephalitis. Rat models are also being used to a lesser extent but have some benefits of consistently reproducing neurological disease and studying the genetic aspects of RVFV. Rat models reproduce meningoencephalitis which more closely mimics human neurological disease. Non-human primate (NHP) models are most applicable to human disease and African green monkey (AGM) as well as marmosets have been shown to be susceptible to RVFV infection. The public health significance of RVFV is the possibility of spread to United States and severe disruption in agriculture as well as the possible use as a biological weapon. 
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Rift Valley Fever Virus is in the Bunyaviridae family of viruses, and is the causative agent of disease in RVFV outbreaks primarily in Sub-Saharan Africa and the Middle East in both animals and humans [1]. The virus was first identified in the Rift Valley of Kenya in 1931 during an investigation into an epidemic among sheep [2]. RVFV is a negative sense single-stranded RNA virus and contains three segments that are surrounded by a lipid bilayer [3]. Mosquitos are both a reservoir and a vector for natural RVFV infection, with vertical transmission in the Aedes mosquito with occasional amplification cycles in livestock and other ruminants as shown in figure 1 [4]. Abnormally high rainfall leads to explosive emergence of the Aedes mosquito and the passing of the virus to other types of mosquitos such as the Culex mosquito which can also pass the virus to ruminants and humans [4]. Ruminant infection with RVFV can result in “abortion storms” and is a major concern for the economic impact it could have on the United States [5].

Figure 1. Rift Valley Fever virus ecology.
CDC virus ecology of RVFV infection of livestock and humans through amplification cycles in mosquitos due to heavier than usual rainfall [6].
1.1	Biological weapon risk
RVFV poses a threat to the United States because of the likelihood of it being used as a biological weapon. RVFV is listed as a select agent by the Centers for Disease Control and Prevention (CDC), as well as a category A pathogen by the National Institutes for Health (NIH) for the bioterrorism capabilities and the formidable economic threat it poses  ADDIN EN.CITE [5, 6]. A majority of human infections occur through direct contact with infected animal tissues but RVFV has been shown to cause more severe and consistent disease through the aerosol exposure route in animal models, resulting in high mortality [7]. A concern is that RVFV could make its way into the America’s the same way that West Nile Virus did. Starting in 1999, West Nile Virus experienced extensive spreading into the America’s because of increased amplification in regards to avian virulence combined with the viral adaption to replicate at higher temperatures [8]. There are presently a number of diverse vectors capable of spreading RVFV in Europe and North American. 
1.2	Disease associated with rvfv infection
RVFV causes a range of disease that include acute febrile illness, ocular disease, hepatic disease, hemorrhagic fever, and encephalitis in humans, as well as “abortion storms” in ruminants and possibly humans [5, 9]. From initial exposure, there is a window of two to six days before symptoms occur in ruminants as well as humans [10]. Most human infections are characterized by mild febrile illness, or symptoms similar to meningitis lasting four to seven days in which host antibodies become detectable [10]. The ocular disease can be temporary or permanent. Generally, retinal lesions are temporary and clear up within 10-12 weeks, but macula lesions have about a 50% chance of permanent vision loss [11]. 
The severe forms of disease include ocular disease, encephalitis, and hemorrhagic fever [5, 10]. Hemorrhagic fever develops quickly, within two to four days of exposure and begins with severe liver impairment with death occurring three to six days after the onset of symptoms. Case fatality rates are very high at approximately 50% for both the encephalitic and hemorrhagic forms [12]. Encephalitis can occur anywhere from one to four weeks after first symptoms occur, but can also occur much later and is relatively rare, but neurological deficits following encephalitis are common and estimated in 8% of cases [10, 13]. 
1.2.1	Neurological illness caused by RVFV
Neurological illness has been historically understudied due to the lack of animal models that recapitulate encephalitis. Previously developed immunocompetent Lewis rat models recapitulate neurological disease seen in humans’ [5]. Clinical data from Lewis rat infections are consistent with human infections, and have been validated as an appropriate small animal model [14]. Non-human primate models, such as Africa green monkeys or marmosets are more desirable since they are more closely related to humans’ [5]. It has also been shown that these two particular NHP models reproduce lethal encephalitic disease from aerosol infection and either could be reliable non-human primate models for further research [5, 14].
1.2.2	Diagnostics and Therapeutics 
Currently, there are no developed therapeutics or licensed vaccines, and generally only supportive therapy is offered for RVFV. The mechanisms of RVFV infections or outcomes are not well understood at this time. According to the World Health Organization (WHO), and the Centers for Disease Control and Prevention (CDC), there have been nine documented outbreaks of RVFV since 2000, which have decreasing time intervals between outbreaks and increasing severity over time [10, 11, 15]. 
Clinical diagnosis is a challenge due to the mechanisms of RVFV not being fully understood to date and no cost effective, quick diagnostic methods available. RVFV is commonly confused with other hemorrhagic diseases, especially in early disease due to the lacking quick field tests and similarities in symptoms and laboratory confirmation is needed to confirm RVFV. Due to the dangers of handling infected tissues, specialty equipment such as biocontainment facilities, and extreme care is needed when handling samples. It is important to understand the mechanisms of RVFV infection using available animal models to develop vaccines and treatments in ruminants as well as humans to combat the possible natural spread, or the intentional release of this disease. Although the hepatic disease is also important, the neurological pathology and limited hemorrhagic disease will be the focus of this review. 
1.3	rvfv histology techniques
Currently the main types of histology being used to evaluate RVFV is Hematoxylin and Eosin staining (H&E), and an assortment of immunohistochemistry (IHC) techniques to include viral antigen staining. H&E staining is the most common technique used to analyze tissues that have been fixed, processed, paraffin-embedded, and sectioned [16]. It involves nucleic acid staining with hemalum which, turns the structure a dark blue, followed by a counterstain with eosin that dyes the protein structures a pink, red, or orange [16]. The combination of hematoxylin and eosin create blue, purple, and red hues [17]. Hematoxylin is basophilic and binds the acidic structures such as DNA and RNA in the nucleus [17]. Conversely, eosin is acidic and binds the positively charged amino side chains like lysine and arginine which cause the cytoplasm to stain pink [17]. These combinations create blue or purple coloration in nuclei, basophils to be a purple/redish tint, cytoplasm to be red, muscle tissue in dark red, erythrocytes in a bright red, and collagen and mitochondria in a pale pink [17]. 
H&E staining allows the visualization of general pathology in the brain to include, but not limited to: meningitis, encephalitis, vasculitis, and meningoencephalitis. Each disease state differs by location of inflammation, and infiltrating lymphocytes commonly seen in these disease states stain a deep purple. Meningitis is the inflammation of the meninges, which is the coating of the brain, while encephalitis is the inflammation of the brain itself [18]. Vasculitis is the inflammation of the vasculature, and lastly, meningoencephalitis is the diffuse inflammation of the brain as well as the membranous lining [11, 18].
Immunohistochemistry uses biochemical techniques to visualize target antigens or markers in tissues [19]. There are many different techniques and methods used to detect a range of targets in immunohistochemistry in RVFV, but there are some general guidelines that are followed which accomplish the goal of tissue preparation and labeling [5, 20, 21]. Immunohistochemistry techniques for RVFV include basic detection of RVFV antigen though chromagen or fluorescent staining, to complex multiplex techniques to detect specific cells, cytokines, or other targets of interest in conjunction with viral antigen. 





Histological examination of human brain tissue from RVFV cases is not common, but has been occasionally examined in large outbreaks such as in South Africa in 1975, in 2000 in Saudi Arabia, and in Kenya in 2006 [3]. Examination of brain tissue from the 1975 outbreak revealed focal areas of necrosis that were characterized by lymphocyte and macrophage recruitment seen in figure 2 [22]. The primary sign of encephalitis was perivascular cuffing of lymphocytes [22]. 
Additional histological examination of the same outbreak by B. M. McIntosh, et al., confirmed the same lymphocyte infiltration and perivascular cuffing in a patient that succumbed to encephalitis [23]. A compilation of human disease reports was completed by Tetsuro Ikegami and Shinji Makino in 2011 that also supported the presence of focal necrosis, perivascular cuffing with lymphocyte and macrophage infiltration, as well as lesions in the brain in the encephalitic forms of RVFV [10]. Tetsuro Ikegami also demonstrated the presence of encephalitis in patients who died from hemorrhagic fever, which indicated there is brain involvement in the hemorrhagic form also [10]. Although neurological tissue from people infected with RVFV is largely unavailable, the small amount of data that we do have is in line with what we have seen in animal models and suggests that through animal model research we can further understand the human neurological disease. 

Figure 2. Human brain histology with RVFV infection.
D. J. J. Van Velden characterized the infection of human brain tissue through histological staining which showed signs of necrosis and infiltrating macrophages and lymphocytes [22]. Imaged magnified at 100x [22].
3.0 	rodent model
Through the discussion of the currently developed animal models, the benefits of each model will be discussed to determine the most beneficial model available for RVFV future research. The limited availability of brain tissue in human cases requires reliance on animal models to further knowledge of the processes of RVFV infection, especially with the neurological aspects. An assortment of animal models have been developed, each of which has benefits and limitations that will be discussed. 
The most studied animal model in RVFV infection is the mouse model. The inexpensive nature and the ability to study larger numbers is a major advantage of the mouse model. Rats, gerbils, and other small rodents can also be inexpensive and as seen in rats, might mimic human neurological disease more accurately. Although not inexpensive, NHP models allow us to study the closest relation to human disease. NHP research is extremely valuable since human disease is impossible to study in a controlled environment. 
The different models have different possibilities of infection routes to replicate natural infection. The most common infection routes include subcutaneous, and aerosol infection. Subcutaneous infection is the injection of virus into the animal model which is representative of mosquito bite infections, and infection from direct contact with animal blood through cuts or abrasions. Aerosol infection is the use of a machine to suspend tiny particles of virus into the air to be inhaled. This reflects what could be seen if RVFV was weaponized.
Rodent models are a cost effective way to study basic mechanisms and to look at larger numbers of animals at a time, but are not always the more representative of human disease modeling. Rodent models include mouse, rat, hamster, and gerbil. Each model has benefits and drawbacks which must be considered when selecting the animal of study.
3.1	Mouse model
The mouse model is the by far the most studied model in RVFV. It is one of the most susceptible species to infection and develops liver disease as well as the delayed neurological disease when they survive the acute disease  ADDIN EN.CITE [10, 24]. A major benefit of the mouse model is the ability to develop genetically modified mice to study cytokine production, genetic components, or other possible targets for RVFV research. Examples are the models lacking the alpha/beta interferon receptor to study interferon responses which are still highly sensitive to RVFV infection  ADDIN EN.CITE [25]. Additionally, HLA-A2 transgenic mice are useful to study the possible T-cell epitopes and responses. Mice depleted of CD4+ T-cells have higher mortality compared to CD8+ T-cell depleted mice, but alternatively, mice with no B-cells had no immune protection at all suggesting a Th2 cellular response being involved in RVFV clearance  ADDIN EN.CITE [25]. Histology completed by Kimberly Dodd et al., shows CD4+ depleted mice to have much more severe encephalitis characterized by lesions with some showing mild infiltration of neutrophils shown in figure 3 [26]. All mice showed a large increase in activated microglia, neuronal necrosis, and scattered neutrophilic invasion, but meningitis was not a common feature [26]. 

Figure 3. H&E staining in brain of a CD4-depleted mouse. 
Dodd shows the H&E staining of a RVFV infected CD4 depleted mouse with encephalitis that is characterized by neutrophil infiltration and neuronal necrosis. The arrows point to infiltrating neutrophils, and the inset at the bottom has arrows pointing to neuronal necrosis [26].

The clinical signs in mice vary from human disease, with lower limb paralysis being a major indicator of neurological involvement, and is usually quickly followed by death [10]. The small amount of mice that survive limb paralysis subsequently die of encephalitis at a later time point [10]. Viral antigens can be detected by immunohistochemistry techniques in a multitude of tissues such as, oral epithelium, glial cells of the pituitary and adrenal glands, olfactory neurons, neuronal cells in the brain, as well as in macrophages [10, 24]. Apoptosis is commonly seen in lymphocytes in the lymph nodes, the mucosa-associated lymphoid tissue, as well as other areas of the CNS in animals infected with RVFV [10, 20]. An early target of aerosol infection was shown to be olfactory neuroepithelium lining the nasal passages [20, 27]. The earliest evidence of viral entry into the brain is thought to be the olfactory bulb followed by the brain stem with neurons being the main target for infection in all viral exposure types shown in figure 4 [20, 24].

Figure 4. IHC staining of the brain stem in a BALB/c mouse.
Smith shows IHC staining of the brain stem of an infected BALB/c mouse 8 days post infection with extensive RVFV infected neurons, which are larger cells, and what is thought to be infected glial cells indicated by arrows [24].

Wiley et al., demonstrated that entry though olfactory bulb is possible, but it does not appear that early infection of the olfactory bulb is a feature of RVFV which is an issue with the theory [28]. The virus could be passing directly through neurons in nasal epithelium or could be entering the CNS by axonal transport. This is supported by the observance of gut epithelial commonly being infected and possibly passing through to the brainstem, using axons to spread to the brain [20, 28].
As seen in human cases, severe forms of disease include necrosis, hemorrhages, and perivascular cuffing in the brain tissue [10]. Infection from exposure to contaminated animal tissues in humans is easily replicated through subcutaneous infection of rats, which induces the hepatic and encephalitic diseases [24]. Although the mouse models reproduce severe disease, encephalitis cannot be reproduced in every mouse, so unless studies are encompassing liver involvement as well as neurological involvement, it is not the most efficient use of animals [1]. It is also unclear what percentage of mice develop encephalitis as seen in a paper published by Gray, et al., where no histological evidence of encephalitis was found in any of the challenge studies to include the ZH501 wild type strain [29]. Alternatively, Reed, et al., demonstrated 30% of mice to have neurological disease resulting in death by subcutaneous infection, and 100% in aerosol infected BALB/c mice [30]. 
The differences in studies could indicate unreliable reproduction of neurological disease in this model. Mice that do have develop encephalitis exhibit widespread encephalitis throughout the brain which is slightly different from human disease [30]. Meningoencephalitis is more common without uniform encephalitis seen with the exception of the aerosol infections that were done by Reed et al., which demonstrated meningoencephalitis [22-24]. 
As mentioned previously, clinical symptoms vary from human disease with the presence of lower limb paralysis [10]. Additionally, mice do not exhibit hemorrhagic fever or ocular disease that is associated with human infections [10]. The mouse model is commonly used in vaccine and treatment studies due to both severe disease manifestations being present, which is a large benefit of this model.
3.2	Rat model
Rats have not been studied as much as mice but have some benefits compared to the mouse model. Rats have varied susceptibility to RVFV depending on the strain of rat, location of breeding, age, and infection route [1, 7, 10]. There are many different types of rats that have been looked at for RVFV research to include: Wistar-Furth (WF), Brown Norway, Fisher 344, Buffalo, Dark Agouti (DA), Lewis, August-Copenhagen-Irish (ACI), Maax [1, 7, 10, 14]. Subcutaneous infection causes death through liver disease in WF, and Brown Norway rats, encephalitic disease in ACI and Maax strains, but Fisher 344, Buffalo, DA, and Lewis rats were much more resistant to RVFV infection [10]. Aerosol infection causes the severe, lethal hepatic disease in WF rats and encephalitis in ACI rats, but lethality was caused at much lower doses in WF rats [7]. Additionally, although Lewis rats were resistant to subcutaneous infection, they develop lethal encephalitis after aerosol infection [7]. See Table 1 below for a summary of the type of rat, infection route and disease outcome. Encephalitis in infected rats with RVFV was defined by lesions in the brain and spinal cord with infiltrating neutrophils and necrosis, as well as perivascular cuffing with lymphocytes [10]. 
WF and Brown Norway rats are much more susceptible to lower doses of virus in both subcutaneous and aerosol infections, and develop lethal hepatic disease [1]. Although the ACI and Maax strains develop encephalitic disease, there is only a 50% mortality rate associated with encephalitic disease, with no apparent signs of liver involvement [1]. High levels of virus can be found in the brain causing neuronal necrosis with neutrophil invasion [1]. Surprisingly, Lewis rats show no clinical signs following subcutaneous infection [1]. There are other studies that contradict these findings in WF and Lewis rats that were bred in Europe, and it was demonstrated that a dominant gene most likely encodes for the resistance to RVFV infection and follows a simple Mendelian pattern [1]. Rats have also been shown to have varying susceptibility to different strains of RVFV, for example, WF rats are highly susceptible to the RVFV strains isolated in the outbreaks in Egypt in the 1970’s with an LD50 of less than 1 pfu, but highly resistant to the African strains isolated from outbreaks from 1944-1979 [1]. Lewis rats were validated in a later study for an applicable model for encephalitis [14]. Histology showed lesions in the brain with meningitis and infiltrating lymphocytes, as well as vasculitis with lymphocytes and neutrophils shown in figure 5 [14]. Additionally, necrosis of infected neurons in the cortex 
Figure 5. H&E staining in the cortex of an infected rat.
Caroline et al., shows H&E staining of the cortex of a RVFV infected Lewis rat 7 days post infection with widespread meningitis and neuronal necrosis [14].

with evidence of apoptosis was seen which is reflective of the limited histological evidence seen in humans [14]. Hartman et al., also concluded that although there is immune infiltrate in areas of meningitis and vasculitis [10, 14]. Co-localization was not seen with viral antigen in IHC staining which suggests the immune cells are not the main target of infection shown in figure 6 [10, 14].  Due to the differences in sensitivity to virus, mainly due to inbreeding, rats are convenient in studying the genetic implications of resistance to RVFV [10]. The different disease outcomes exhibited after subcutaneous infection mimic the range of disease outcomes seen in humans, which could provide a reliable and repeatable model for studying different disease outcomes as well as testing vaccines and treatments [7]. The encephalitis seen in rats also reflects more accurately the disease seen in humans with meningoencephalitis being more common with perivascular cuffing with lymphocytes being an indicator of encephalitis as opposed to the panencephalitis seen in mouse models. WF and ACI rats seem to be representative of human hepatic and neurological disease after inhalation exposure [7]. Aerosol infection has been shown to be much more virulent at lower doses of virus and can be used to study the neurological disease.

Figure 6. IHC staining in the cortex of an infected rat.
Caroline et al., shows IHC staining of the cortex of an infected Lewis rat 7 days post infection with RVFV infected neurons and the recruitment of lymphocytes [14].










Table 1. Disease Outcome by Rat and Infection Route.
			Disease Outcome
		Lethal Liver Disease	Lethal Encephalitis	No Disease
Infection Route	Subcutaneous Infection	WFBrown Norway	ACIMaax	Fisher 344BuffaloDALewis
	Aerosol Infection	WFBrown Norway	ACIMaaxLewis	Fisher 344BuffaloDA
Summary of disease outcomes seen in rats dependent on infection route.

neurological disease that mimics human outcomes can be reproduced and further studied. It is also thought that the rat models are representative of human cytokine response, which could be very helpful in understanding disease outcomes associated with RVFV [14].
3.3	other rodent models
Other rodent models have been studied such as the Syrian hamster and gerbil [10, 14, 31]. The Syrian hamster was shown to also be another very susceptible animal to RVFV infection, not only in a laboratory setting but also in natural outbreaks [10, 32]. Hamsters develop severe liver disease as seen in mice, but hamsters are protected from subsequent RVFV hepatic disease through neutralizing antibodies but they develop fatal encephalitis [10]. The gerbil provided a repeatable encephalitic disease, but it is dependent on age, as seen in rats [10, 14, 31]. There was minimal liver involvement, and caused fatal encephalitis in 100% of infected gerbils at three weeks of age, but decreased to 20% mortality at 10 weeks of age [31]. IHC showed viral antigen staining in the brain with encephalitis, neutrophil invasion, and neuronal necrosis in subcutaneous as well as intracerebrally infected animals [31]. The gerbil model could be useful in studying the encephalitic disease without liver involvement, and the hamster model could be useful in studying the liver disease [10, 31].

4.0 	Nhp models
NHP models are more costly and require more training and expertise, but they allow us to more accurately reflect human disease. The first monkeys to be infected with RVFV and studied were rhesus macaques in 1931 [33]. They were found to only produce a mild febrile response, but most often was not fatal [33]. Rhesus and cynomologus macaques were also infected by the aerosol route, in which they were slightly more susceptible to compared to other infection routes, but most cases were not fatal [34]. Previous studies have shown South American as well as Indian monkeys to be more susceptible to RVFV infection than African monkeys [35].
4.1	macaque MODEL
Originally it was thought that rhesus monkeys provided the best model for human infection [1, 33, 35]. These monkeys have three disease outcomes to include 18% with fatal disease, 41% that are clinically ill survivors, and 41% that have very mild or no disease at all [1]. The severe disease in rhesus monkeys is liver necrosis and hemorrhagic symptoms [1]. Additional studies looking at the rhesus model had 100% survival with no apparent clinical illness other than mild fever and one animal presenting with brain histology with inflammation of lymphocytes and an increase of activated microglia [5, 10, 36, 37]. Due to the difficulty in producing severe disease and lacking neurological histology,  the macaque model is not the most efficient NHP model.
4.2	marmoset MODEL
Through all infection routes, marmosets had about a 50% mortality rate with 75% of them presenting with clinical signs of neurological impairment [36]. The animals infected through intranasal route had a 100% mortality with clear clinical signs of neurological disease [36]. Surprisingly, another studied looked at aerosol infection on marmosets and found that all developed biphasic fevers but only a 50% mortality due to encephalitis [5]. High levels of virus could be found in the brain, but not in the CSF, as well as meningitis with infiltration of lymphocytes and neutrophils, and perivascular cuffing of lymphocytes shown in figure 7 [5, 36]. Histological staining showed fragmented nuclei which is a classic sign of neuronal apoptosis [5, 36]. Co-localization of viral staining and neuronal staining indicated infection of neurons directly, but not with lymphocytes, which has previously been documented and is shown in figure 8 [5, 36]. This reflects the severe neurological disease seen in humans. Additionally, a monkey in one of the studies also developed signs of hemorrhagic disease after intravenous exposure to RVFV, but not through any other exposure types [36]. 
This is not seen with macaque models and could be useful in depicting the hemorrhagic fever seen in 1% of human cases. The susceptibility and predictable disease outcome, especially with intranasal infection could lend a better model for encephalitis compared to macaques [36].

 
Figure 7. H&E staining in a marmoset.
Hartman et al., shows meningitis characterized by lymphocyte invasion with H&E staining of the brain of a RVFV infected marmoset [5].
4.3	African green monkey MODEL
A natural history study done on African green monkeys (AGM) in 2014 showed the usefulness of AGMs as a possible NHP model [5]. All of the AGMs exposed by aerosol developed a single phase fever, and five of the six died from disease [5]. The one survivor was the AGM exposed to the lowest amount of virus at 4.9 log10 PFU [5]. The five AGM’s that developed neurological disease showed clinical signs and had high levels of virus in the brain and spinal cord, but not in the CSF [5]. The histological evidence was primarily in the brain and not in the liver, and 


Figure 8. IHC staining in a marmoset.
Hartman et al., demonstrates the co-localization of RVFV and neurons with IHC staining in the hippocampus of a RVFV infected marmoset [5].

included meningitis with lymphocyte infiltration as well as perivascular cuffing of lymphocytes, and signs of neuronal apoptosis [5]. As seen in marmosets, there was co-localization of virus and neuronal cells indicating direct infection of those cells but not in lymphocytes shown in figure 9 [5]. Infection through the subcutaneous route does not produce any clinical illness in AGMs [5]. Although marmosets do produce severe RVFV disease through intranasal infection, this type of infection route is not a good replacement for aerosol infection, lending to the idea that AGMs could possibly be the best option for a NHP model in RVFV research [5]. Both marmosets and AGMs mimic histology findings in human brain tissue of infected individuals with encephalitis through infiltrating lymphocytes and perivascular cuffing of lymphocytes [5].

Figure 9. IHC staining in an AFG.
Hartman et al., shows the co-localization of RVFV and neurons in the brain of a virally-infected AGM with IHC staining [5].

5.0 	Conclusion
There are benefits and disadvantages to each model and the goal of the research is important to consider when choosing which model to utilize. There are still many unknowns about the mechanisms of RVFV, especially in neurological disease, highlighting models as an invaluable resource. Histology techniques such as multiplex immunofluorescent staining have progressed recently and could be used to further clarify many aspects of viral invasion of the brain. Although there are limited sources for RVFV histology at the current time, especially in human cases, there are related viruses that can be used to progress the field. Testuro Ikegami hypothesizes the relatedness to Punta Toro virus, which is a phlebovirus and has speculated that RVFV could penetrate the basolateral membrane and contribute to quick systemic viral spread [10]. Histological evidence has shown the infection and replication of RVFV in polarized epithelial cells at the basolateral membrane which could support RVFV acting like Punta Toro virus and spreading through that manner [10, 38]. 
Additionally, the immune response uses IL-6 as a protective type of immunity against the disease like Punta Toro virus which is supported as a protective mechanism in RVFV infection also [10]. Other sources have looked at the possibility of spread through the nasal epithelium or possibly olfactory neurons [24, 27, 39]. Histology could be used as a tool to add evidence to cell types being infected and routes of infection that are occurring. Basic mechanisms of RVFV are yet to be clarified and much work is needed in the field to further understand RVFV’s looming threat. West Nile Virus shows that the virus could spread into the United States naturally causing major economic issues in the agricultural field as well as a threat to human health. Developing therapeutics and understanding the clinical implications is of utmost importance now that we understand how lethal RVFV is when aerosolized, which can most effectively be done using a plethora of animal models to complete the understanding of RVFV.
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